Immunity in Hodgkin's Disease After 10 Years of Remission
Author Information
Author(s): L.J. Bruce, B.W. Hancock
Primary Institution: YCRC University Department of Clinical Oncology, Royal Hallamshire and Weston Park Hospitals, Sheffield, UK
Hypothesis
What is the status of immunity in patients with Hodgkin's disease after 10 years of remission?
Conclusion
Most patients with Hodgkin's disease maintain improved immune function after 10 years of remission, although some immunological parameters remain depressed.
Supporting Evidence
- 15 out of 16 patients were in remission after 10 years.
- Neutrophil counts returned to near presentation levels at 10 years.
- Lymphocyte and monocyte counts were significantly higher at 10 years than at presentation.
- Immunoglobulin levels rose over the 10-year period, returning to near presentation levels.
- Cellular immune responses were impaired in the one patient who had a recurrence.
Takeaway
This study looked at how the immune system of Hodgkin's disease patients changed over 10 years after treatment, finding that while many improvements occurred, some issues remained.
Methodology
Patients were assessed immunologically at various points: at presentation, after treatment, and at 1, 5, and 10 years of remission using several blood tests.
Limitations
The study used older immunological tests, which may not reflect current understanding or techniques.
Participant Demographics
Patients included both those who had undergone splenectomy and those who had not, with a mix of treatment types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website